MedPath

Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies.

Not yet recruiting
Conditions
Bone Disorder
Interventions
Other: Biological samples
Other: Biological
Registration Number
NCT06444503
Lead Sponsor
University Hospital, Toulouse
Brief Summary

The aim of this project is to set up a biological and clinical collection of patients with progressive bone, calcium and growth plate pathologies.

This collection will provide a better understanding of the mechanisms involved in growth plate and bone damage in these diseases and identify factors predictive of progression and new therapeutic targets.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
350
Inclusion Criteria
  • Children (from birth) with growth plate or bone pathology
  • Patients affiliated to or benefiting from a social security scheme
  • Patients able to receive information about the study and to understand the information form in order to participate in the study. This implies :
  • mastery of the French language
  • Not being subject to a restriction of rights by the judicial authorities
  • Patients or legal representatives having given their consent to participate in the study (expression of non-opposition).
Exclusion Criteria
  • Patients under legal protection (guardianship, curatorship or safeguard of justice)
  • Pregnant or breast-feeding women

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients suffering from growth plate or bone pathologyBiological samplesAs part of their pathology, patients benefit from clinical monitoring and regular blood and urine tests.
Patients suffering from growth plate or bone pathologyBiologicalAs part of their pathology, patients benefit from clinical monitoring and regular blood and urine tests.
Primary Outcome Measures
NameTimeMethod
Building a collection of biological samples and clinical-biological data from patients presenting bone, calcium and growth plate pathologiesDay 0 and through study completion, an average of 5 years

Blood and urine sampling

Secondary Outcome Measures
NameTimeMethod
Identification of potential markers of disease progression based on new knowledge.Day 0 and through study completion, an average of 5 years

Trial Locations

Locations (1)

University Toulouse Hospital

🇫🇷

Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath